Clinical Trial: Bioequivalence Study Between YHP2508A and YHR2601 in Healthy Subjects

U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07912827) titled 'Bioequivalence Study Between YHP2508A and YHR2601 in Healthy Subjects' on Oct. 28.

Brief Summary: An open-label, randomized, fasting, single-dose, oral administration, 2-sequence, 4-period, replicate crossover study to evaluate bioequivalence between YHP2508A and YHR2601 in healthy subjects

Study Start Date: Oct. 20

Study Type: INTERVENTIONAL

Condition: Healthy Subjects (HS)

Intervention: DRUG: YHP2508A

Test Drug

DRUG: YHR2601

Comparator drug

Recruitment Status: RECRUITING

Sponsor: Yuhan Corporation

Published by HT Digital Content Services with permission from Health Daily Digest....